Young Teresa L.
See Remarks
Young Teresa L. has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Young Teresa L. is listed as See Remarks at Seres Therapeutics, Inc. Inside the rolling window, Young Teresa L. reported no open-market purchases and 2 open-market sales totaling $19K in MCRB. The largest disclosed transaction in the window is a sale of 1,042 MCRB shares on Nov 15, 2025, worth $18K.
Companies traded
Other insiders at MCRB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Young Teresa L. made?
Young Teresa L. has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Young Teresa L. trade?
Young Teresa L. has filed SEC Form 4 disclosures for 1 company, including MCRB.
When was Young Teresa L.'s most recent SEC Form 4 filing?
Young Teresa L.'s most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Young Teresa L.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Young Teresa L. is listed as See Remarks.
What is Young Teresa L.'s total buy and sell value in the current window?
Inside the rolling retention window, Young Teresa L. bought $0 and sold $19K based on SEC Form 4 filings.
What was Young Teresa L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,042 MCRB shares on 2025-11-15, worth $18K, per SEC Form 4 filings.